|
124 Companies |
|
161 Products |
|
161 Products |
|
116 Mechanisms of Action |
|
11 Trials |
|
2428 News |
|
| «12...2223242526272829303132...4950» |
- | NN1213 / Novo Nordisk
Trial completion: Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults (clinicaltrials.gov) - Feb 22, 2014
P1/2, N=24, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=75, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Pneumococcal vaccines: Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2 (clinicaltrials.gov) - Feb 22, 2014
P2, N=620, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=158, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: HIV Prevention Preparedness Study (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=1200, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Marijuana for HIV-Related Peripheral Neuropathy (clinicaltrials.gov) - Feb 22, 2014
P1/2, N=50, Completed, Sponsor: Center for Medicinal Cannabis Research
No longer recruiting --> Completed Recruiting --> Completed
- | niacin extended-release formulation / Generic mfg.
Trial completion: Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=30, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed No longer recruiting --> Completed
- | Invirase (saquinavir) / Roche
Trial completion, Combination therapy: Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects (clinicaltrials.gov) - Feb 22, 2014
P2, N=30, Completed, Sponsor: Abbott
No longer recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor (clinicaltrials.gov) - Feb 22, 2014
P3, N=360, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed Active, not recruiting --> Completed
- |||| ritonavir / Generic mfg., fosamprenavir / Generic mfg.
Trial completion: A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years (clinicaltrials.gov) - Feb 22, 2014
P2, N=69, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Endothelial Dysfunction as a Risk Factor in HIV Study (clinicaltrials.gov) - Feb 22, 2014
P1, N=75, Completed, Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting --> Completed Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: A Study of Peer Education to Prevent HIV Transmission Among Injection Drug Users and Their HIV Risk Contacts (clinicaltrials.gov) - Feb 22, 2014
P3, N=2610, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed Terminated --> Completed
- ||||||| Trial completion, Combination therapy: Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV (clinicaltrials.gov) - Feb 22, 2014
P3, N=571, Completed, Sponsor: Bristol-Myers Squibb
Terminated --> Completed Active, not recruiting --> Completed
- | Ampligen (rintatolimod) / AIM ImmunoTech
Trial completion: The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART (clinicaltrials.gov) - Feb 22, 2014
P2, N=40, Completed, Sponsor: Hemispherx Biopharma
Active, not recruiting --> Completed Recruiting --> Completed
- | Viracept (nelfinavir) / ViiV Healthcare, Roche, NN1213 / Novo Nordisk
Trial completion: Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children (clinicaltrials.gov) - Feb 22, 2014
P1, N=34, Completed, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials (clinicaltrials.gov) - Feb 22, 2014
P1, N=54, Completed, Sponsor: HIV Vaccine Trials Network
No longer recruiting --> Completed Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: A Study to Prepare for Future HIV Vaccine Studies (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=0, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, Combination therapy: Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s) (clinicaltrials.gov) - Feb 22, 2014
P3, N=0, Completed, Sponsor: Bristol-Myers Squibb
Active, not recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: A Comparison of Two Ways to Manage Anti-HIV Treatment (The SMART Study) (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=6000, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed Terminated --> Completed
- | tenofovir disoproxil fumarate / Generic mfg.
Trial completion: Tenofovir Disoproxil Fumarate to Treat Pediatric HIV (clinicaltrials.gov) - Feb 22, 2014
P1, N=30, Completed, Sponsor: National Cancer Institute (NCI)
Terminated --> Completed No longer recruiting --> Completed
- | Mycobutin (rifabutin) / Pfizer, Lupin
Trial completion, Combination therapy: TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz (clinicaltrials.gov) - Feb 22, 2014
P2, N=20, Completed, Sponsor: Centers for Disease Control and Prevention
No longer recruiting --> Completed No longer recruiting --> Completed
- || Juluca (dolutegravir/rilpivirine) / ViiV Healthcare, J&J
New P2/3 trial, Head-to-Head: Dolutegravir + Rilpivirine Switch Study (DORISS) (clinicaltrials.gov) - Feb 20, 2014
P2/3, N=300, Not yet recruiting, Sponsor: Nantes University Hospital
- | NN1213 / Novo Nordisk
Trial completion: HIV and Genital Herpes Among High-Risk Men Who Have Sex With Men (MSM) in Lima, Peru (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=250, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Acupressure to Treat Nausea and Vomiting in HIV/AIDS Patients (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: National Institute of Nursing Research (NINR)
No longer recruiting --> Completed Recruiting --> Completed
- | medroxyprogesterone injection / Generic mfg.
Trial completion: Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=76, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed No longer recruiting --> Completed
- | rosiglitazone / Generic mfg.
Trial completion: Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=105, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed No longer recruiting --> Completed
- Trial completion, Combination therapy: A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine (clinicaltrials.gov) - Feb 19, 2014
P3, N=0, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- | ALVAC-HIV / National Institute of Allergy and Infectious Diseases, Sanofi
Trial completion, IO biomarker: Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load (clinicaltrials.gov) - Feb 19, 2014
P2, N=92, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed No longer recruiting --> Completed
- | Proleukin (aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap, NN1213 / Novo Nordisk
Trial completion: Interleukin-2 Plus Antiretroviral Therapy for HIV-Infected Patients With Low CD4+ Counts (SILCAAT Study) (clinicaltrials.gov) - Feb 19, 2014
P3, N=1695, Completed, Sponsor: University of Minnesota - Clinical and Translational Science Institute
No longer recruiting --> Completed Active, not recruiting --> Completed
- |||| NN1213 / Novo Nordisk
Trial completion: Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis (clinicaltrials.gov) - Feb 19, 2014
P2, N=60, Completed, Sponsor: InterMune
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Trial completion: Carotid Artery Thickness in HIV Infected and Uninfected Adults (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=132, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Hormonal Birth Control and the Risk of Acquiring HIV (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=6360, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
No longer recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: A Study of Chlorhexidine in the Prevention of HIV-1 Transmission From Mothers to Their Babies (clinicaltrials.gov) - Feb 19, 2014
P2a, N=150, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed Active, not recruiting --> Completed
- ||||||| stavudine / Generic mfg.
Trial completion, Combination therapy: Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients (clinicaltrials.gov) - Feb 19, 2014
P3, N=730, Completed, Sponsor: Bristol-Myers Squibb
Active, not recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Observing Patients With Early HIV Infection (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=10, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=81, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed No longer recruiting --> Completed
- |||| lopinavir/ritonavir / Generic mfg.
Trial completion, Combination therapy: ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Na (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=100, Completed, Sponsor: Abbott
No longer recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: A Study on the Safety and Anti-HIV Activity of HE2000 in HIV-Infected Patients on Salvage Therapy (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=42, Completed, Sponsor: Harbor Therapeutics
No longer recruiting --> Completed No longer recruiting --> Completed
- Viracept (nelfinavir) / ViiV Healthcare, Roche, NN1213 / Novo Nordisk
Trial completion: A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=0, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- ||||||| Crixivan (indinavir sulfate) / Merck (MSD), NN1213 / Novo Nordisk
Trial completion: The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine (clinicaltrials.gov) - Feb 19, 2014
P3, N=80, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- ||| Crixivan (indinavir sulfate) / Merck (MSD)
Trial completion: A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=200, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- NN1213 / Novo Nordisk
Trial completion: A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV (clinicaltrials.gov) - Feb 19, 2014
P3, N=0, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: A Study of Lobucavir in Patients With AIDS (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=30, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- | stavudine / Generic mfg.
Trial completion: A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection. (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=40, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- | megestrol / Generic mfg.
Trial completion: The Safety and Effectiveness of Megace in HIV-Infected Women (clinicaltrials.gov) - Feb 19, 2014
P4, N=40, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- stavudine / Generic mfg.
Trial completion: A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=0, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- stavudine / Generic mfg., zidovudine / Generic mfg.
Trial completion: A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=0, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- megestrol / Generic mfg.
Trial completion: A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- nystatin oral / Generic mfg.
Trial completion: A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=0, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- || stavudine / Generic mfg.
Trial completion: A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex (clinicaltrials.gov) - Feb 19, 2014
P3, N=20, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed